+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inotek Pharma - logo

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts. It is focused on the development and commercialization of therapies for glaucoma and other serious diseases of the eye. The company's lead product candidate is Trabodenoson, formerly known as INO-8875, which is in Phase III clinical trials for lowering IOP. Trabodenoson has completed Phase 1, 2, and 3 clinical trials in subjects with OHT and POAG. Inotek was founded in 1999.

Global Glaucoma Treatment Market by Indication (Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma), Type (Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors), Sales Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Glaucoma Treatment Market by Indication (Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma), Type (Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors), Sales Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Global Open-Angle Glaucoma Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Open-Angle Glaucoma Therapeutics Market 2023-2027

  • Report
  • September 2023
  • 161 Pages
  • Global
From
Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Optic Nerve Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Optic Nerve Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Glaucoma Therapeutics Market Report by Drug Class, Indication, End User, and Region 2023-2028 - Product Thumbnail Image

Glaucoma Therapeutics Market Report by Drug Class, Indication, End User, and Region 2023-2028

  • Report
  • November 2023
  • 145 Pages
  • Global
From
Global Glaucoma Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Glaucoma Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 173 Pages
  • Global
From
Glaucoma Treatment Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Glaucoma Treatment Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 88 Pages
  • Global
From
Glaucoma Treatment Market - Growth, Trends, and Forecast (2020 - 2025) - Product Thumbnail Image

Glaucoma Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

  • Report
  • August 2020
  • 114 Pages
  • Global
From
Adenosine A1 Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A1 Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A3 Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 12 Results (Page 1 of 1)
Loading Indicator